ClinicalTrials.Veeva

Menu

Clinical Efficacy of Nail Brace for Treatment of Ingrown Toenails

T

Taipei Medical University

Status

Unknown

Conditions

Ingrown Nail

Treatments

Device: Combiped nail brace
Device: Podofix and then Combiped nail brace
Device: Podofix nail brace

Study type

Interventional

Funder types

Other

Identifiers

NCT03008629
N201610005

Details and patient eligibility

About

Background: Ingrown toenails are one of the most frequent nail disorders and can be treated with conservative or surgical approaches. Although discovered a long time ago, the available data are still very limited on the potential effectiveness of nail braces for ingrown toenail treatment.

Objective: This study aimed to evaluate the efficacy of nail brace (combiped and podofix) for treatment of ingrown toenails.

Full description

Method: Participants with ingrown toenail and >= 12 years old with total 40 ingrown toenails were included. Investigators divide patients to 3 group: (1) combiped group: Participants with non-infected or mild infected ingrown nail, combiped nail brace was applied instantly.20 patients(2) combine combiped and podofix group: Participants with severe paronychia with pyogenic granuloma, oral analgesics and antibiotics were prescribed first and nail brace was applied 1 week later. Depends on disease condition, investigators applied 1-2 combiped nail brace. If the pyogenic granuloma is not resolved after 1 week, investigators applied podofix first for 2-4 weeks and then combiped nail brace. After the nail brace applied, participants must come back between 2-4 weeks depends on disease condition.10 patients (3) podofix group: participants who are afraid of combiped implantation, or with mild recurrence will be applied with podofix.

Participants come back every month for evaluation and photography. Physician global assessment (0-6),Patient global assessment (VAS 0-10), Treatment satisfaction (VAS 0-10), and questionnaire were evaluated 1 month, 3 months and 6 months after the device applied. Participants need to be followed for recurrence at 3rd month and 6th month after removed the nail brace.

Enrollment

40 estimated patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • more or equal to 12 years old patient with ingrown toenail

Exclusion criteria

  • < 12 years old
  • under other nail bracing use
  • received partial nail resection within recent 2 months
  • psoriatic nail
  • target therapy related paronychia
  • received combiped or podofix previously and removed within recent 6 months

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 3 patient groups

Podofix nail brace
Experimental group
Description:
for mild ingrown toenails
Treatment:
Device: Podofix nail brace
Combiped nail brace
Experimental group
Description:
for Severe dystrophic ingrown toenails
Treatment:
Device: Combiped nail brace
Podofix and then Combiped nail brace
Experimental group
Description:
for Ingrown toenails with pyogenic granuloma
Treatment:
Device: Podofix and then Combiped nail brace

Trial contacts and locations

0

Loading...

Central trial contact

Yu Chen Huang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems